Fairfax Media network navigation

  • Home
  • Shares
  • Share details

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED (MVP)


Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today » it's FREE! Already a member? Login now!


General Information
Company Name: Medical Developments International Limited
Stock Code: MVP
Website: www.medicaldev.com
GICS Sub-Industry: Pharmaceuticals
Market Cap ($M): 76
Equiv. Shares (M): 57

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
$ 1.315 $ 1.305 $ 1.315 $ 1.260 $ 1.315 96,800 0%

Company Overview

Business Description:
Medical Developments International Limited (MVP) is an Australia-based healthcare company. The company operates in three segments, being Pharmaceuticals (sale of Penthrox); Medical Device (sale of particularly the Space Chamber and Breathy-Alert Peak-Flow meter); and Veterinary Products. The Company operates world-wide including Australia; New Zealand; and International comprising Eastern Europe, Germany, Canada, Middle East, and South America.

Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2012  A 2.7 5.1 50.0 11.2 6.0 10.6 100.0
2011  A 1.7 3.4 100.0 10.2 3.0 8.7 100.0
2010  A 0.9 1.7 13.3 10.3 0.0 0.0 --
Source: Aspect actuals / Thomson IBES estimates

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2010 A 2011 F 2012 F 2010 A 2011 F 2012 F 2010 A 2011 F 2012 F
Acrux Limited (ACR) $593 M -0.8713 0.9685 0.7483 80.1802 40.7323 23.2984 0.0225 0.0211 0.0491
Medical Developments International (MVP) $72 M 0.4926 -- -- 24.7036 -- -- 0.0480 -- --
Pharmaxis (PXS) $48 M -- -- -- -- -- -- 0.0000 -- --

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
MVP 0.36 26.0 4.53 -- 6.21
Market 0.94 12.5 0.82 1.96 2.44
Sector 1.28 15.2 2.36 0.58 7.16

Directors
Name Position Start Date
Mr David John Williams Non-Executive Chairman,Non-Executive Director 16 September 2003
Mr Allan D McCallum Non-Executive Director 27 November 2003
Mr Maurice Van Ryn Non-Executive Director 27 November 2003
Mr Harry Frank Oxer Non-Executive Director 28 December 2006
Mr Robert (Max) Maxwell Johnston Non-Executive Director 05 November 2012

Management
Name Position
John Stewart Sharman Chief Executive Officer
Wendy Gouveia Company Secretary

Substantial Shareholders
Holding Name
25,504,321 (49.66%) Williams, David John
4,759,740 (9.27%) JP Morgan Nominees Australia Limited

Calendar of Events
Date Event
21 February 2014 Report (Interim)
19 September 2013 Report (Annual)
22 August 2013 Report (Prelim)
21 August 2013 Report (Prelim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.

Advertisement

Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Debt Relief

An educational booklet to help you take control of your debts and look to get back on track.

More details...

News

Investors positive ahead of Fed meeting

The Age 20/06/2013 | The sharemarket gained ground as investors took a cautiously optimistic stance before a keenly awaited update on economic stimulus measures in the United States.

Is New News a good news story?

The Age 20/06/2013 | Pre-split trading of shares in "New Newscorp," the print media-heavy spin-out from News Corp began quietly on Wednesday, and it will take a while to work out where the new vehicle is headed.

News Corp split has one company up, one company down

The Age 20/06/2013 | The two separately listed companies of News Corporation had a subdued first day of trading on the ASX before their demerger later this month.

Lehman's US arm pulls plug on $210m deal with investors

The Age 20/06/2013 | Local councils that lost millions on investments made through Lehman Brothers have suffered a major setback, after the US arm of the failed bank blocked a deal that would have delivered the investors up to $210 million.

Smart and skinny

The Age 20/06/2013 | China's Huawei has vowed to catch up with rivals Apple and Samsung as it unveiled its newest device — the Ascend P6, which it described as the world's thinnest smartphone.

Investors positive ahead of Fed meeting

Sydney Morning Herald 20/06/2013 | The sharemarket gained ground as investors took a cautiously optimistic stance before a keenly awaited update on economic stimulus measures in the United States.

More...

Sponsored Links
Feedback Form